-
Optimal framework for the state regulation of hemp cannabinoids
The hemp cannabinoid market has grown into a $3 billion interstate industry.
-
The implications of federal cannabis rescheduling
While the optimal solution would be to remove cannabis from the list of controlled substances entirely, moving it to Schedule III presents both immediate and long-term advantages over its current Schedule I designation.
-
Getting cannabis legalization right in Hawaii
Hawaii may be poised to become the 25th state to legalize the recreational use of cannabis for adults aged 21 and over.
-
A framework for federal and state hemp-derived cannabinoid regulation
The growing popularity of hemp-derived products has stimulated significant legislative attention in recent years, with over 90 regulatory proposals introduced in state legislatures in 2024 alone.
-
How state reforms changed federal enforcement of marijuana prohibition
While formal federal marijuana law has persisted unchanged amid state-level reforms, federal marijuana enforcement on the ground has changed dramatically.
-
How drug decriminalization affects policing
With the diminished capacity and incentive to pursue drug possession arrests, police can redirect resources toward crimes with victims, crime prevention, and public safety.
-
FAQ: Timeline for FDA ibogaine approval
It can take between 5 and 12 years to complete a drug trial, but the timeline to drug approval can vary significantly depending on the type of treatment.
-
A policy framework for personal psychedelics licenses
Psychedelic licenses for consumers have advantages over the current approach in two U.S. states that rely on professionals to dispense and facilitate services.
-
K-12 open enrollment in Wisconsin: Key lessons for other states
Wisconsin's public school open enrollment program serves over 70,000 students and can be a model for other states.
-
Ibogaine offers major promise in treating addiction, mental health
Ibogaine has the potential to transform the lives of millions of Americans struggling with addiction and mental health challenges.
-
Ibogaine could transform public spending on opioid treatment
Using ibogaine as a treatment for opioid use disorder could be significantly more cost-effective than traditional medication-assisted treatments.
-
Modernizing psilocybin policy to improve mental health outcomes
Psychedelics have the potential to be more effective than conventional drugs now being used to treat a range of mental health disorders.
-
Ibogaine treatment for opioid use disorder
Policymakers should consider ibogaine as a potential alternative treatment for opioid use disorder.
-
Psychedelic treatment for neurodegenerative disorders
Recent research suggests that psychedelics, such as psilocybin and LSD, show strong potential as effective treatments for neurodegenerative disorders.
-
Video Game Loot Boxes: Anatomy of a Moral Panic
There is no evidence to suggest that loot box spending is excessive among adults or adolescents or that it is responsible for any widespread harm.
-
The case for Connecticut’s fiscal guardrails
The “fiscal guardrails” have saved Connecticut more than $170 million and could save $7 billion over the next 25 years.
-
Report: State and local governments have $6.1 trillion in debt
State and local debt is over $100 billion in 16 states and exceeds $50 billion in 27 states. California’s state and local governments have over $1 trillion in debt.
-
Report ranks every state’s debt, from California’s $497 billion to South Dakota’s $2 billion
Study finds state governments have a total of $2.7 trillion in debt, with 26 states exceeding $20 billion in debt each and 10 states over $70 billion.